Navigation Links
Kindred Biosciences Announces Second Quarter 2014 Financial Results
Date:8/13/2014

the following:  our limited operating history and expectations of losses for the foreseeable future; the absence of revenue from our product candidates for the foreseeable future; our potential inability to obtain any necessary additional financing; our substantial dependence on the success of our lead product candidates, which may not be successfully commercialized even if they are approved for marketing; the effect of competition; our potential inability to obtain regulatory approval for our existing or future product candidates; our dependence on third parties to conduct some of our development activities; our dependence upon third-party manufacturers for supplies of our product candidates; uncertainties regarding the outcomes of trials regarding our product candidates; our potential failure to attract and retain senior management and key scientific personnel; uncertainty about our ability to develop a satisfactory sales organization; our significant costs of operating as a public company; our potential inability to obtain patent protection and other intellectual property protection for our product candidates; potential claims by third parties alleging our infringement of their patents and other intellectual property rights; our potential failure to comply with regulatory requirements, which are subject to change on an ongoing basis; the potential volatility of our stock price; and the significant control over our business by our principal stockholders and management. 

For a further description of these risks and other risks that we face, please see the risk factors described in our filings with the U.S. Securities and Exchange Commission (the SEC), including the risk factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2013 and any subsequent updates that may be contained in our Quarterly Reports on Form 10-Q filed with the SEC.  As a result of the risks described above and in
'/>"/>

SOURCE Kindred Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
2. Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center
3. Pressure BioSciences, Inc. to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
4. Ambit Biosciences Announces Second Quarter 2014 Operating Results
5. Neurocrine Biosciences Reports Second Quarter 2014 Results
6. Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
7. Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
8. Ambit Biosciences To Announce Second Quarter 2014 Financial Results
9. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics Targeted Next Generation Sequencing Testing Platform
10. Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
11. Meditope Biosciences Appoints Prominent Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015  Maquet Medical Systems ... signed an exclusive distribution agreement with Flight Medical ... the Flight 60 mechanical ventilator. The Flight 60 ... and affordable mobility. Starting in the first quarter ... in the United States ...
(Date:3/2/2015)... , March 2, 2015 Valencia Technologies ... th patient with its radically small device for ... 2015. Valencia,s early results in this randomized, double-blinded, controlled trial ... degree of confidence that it will succeed in a ... its early clinical results, Valencia ...
(Date:3/2/2015)... BOULDER, Colo. , March 2, 2015 /PRNewswire/ ... regarding close of their transactions, Array BioPharma Inc. ... the binimetinib and encorafenib definitive agreements with Novartis.  ... will receive an upfront payment of $85 million ... of Array, noted, "With the close of the ...
Breaking Medicine Technology:Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5
... 5, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... in China, announced today the resignation of Jacob Chik Keung ... has initiated an executive search for a new Chief Financial ... with the Company until August 16, 2011.  Ms. Nan Wang, ...
... 2011 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), ... platforms to develop treatments in areas of oncology, cancer ... full service global public relations firm, to support its ... a media communications outreach program primarily aimed at introducing ...
Cached Medicine Technology:Sinovac Announces Management Changes 2Sinovac Announces Management Changes 3Access Pharmaceuticals Retains Edelman as Public Relations Firm 2Access Pharmaceuticals Retains Edelman as Public Relations Firm 3
(Date:3/2/2015)... Over the last five years the ultrasound market has ... their geographic presence and achieve economies of scale. The ... by 2019 at CAGR of 5.1% from 2014 to ... and a major part of Europe are mature markets ... including China and India, Latin America and the Middle ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... WI (PRWEB) March 02, 2015 ... consultancy focused on quality, regulatory and technical consulting, ... as Chief Operating Officer. , Before joining ... experience leading R&D teams in all aspects of ... leadership positions at Covidien (Medtronic), Regulatory Compliance Associates ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today announced ... serve as chief safety officer. In this role, he ... and guide remediation efforts in all factories from which ... the Alliance continues to bring world-class expertise to factory ... said Alliance Independent Chair Ellen Tauscher. “His role as ...
(Date:3/2/2015)... Aliso Viejo, California (PRWEB) March 02, 2015 ... the release of the TranStatic Volume 2 from Pixel Film ... glitch transitions made exclusively for FCPX,” said Christina Austin, CEO ... tool to have in any Final Cut Pro X editors ... one scene to the next with media altering static scrambling ...
Breaking Medicine News(10 mins):Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2
... a new country is difficultlearning the cultural rules and meanings ... published in Psychological Science , a journal of the ... for children, but quickly becomes more difficult after about the ... many aspects of learning and development have a critical windowif ...
... is a great way to stay physically active while ... is that mountain biking-related injuries have decreased. A new ... Research and Policy of The Research Institute at Nationwide ... decreased 56 percent over the 14-year study period (1994 ...
... WEDNESDAY, Feb. 2 (HealthDay News) -- A large international trial finds ... as well as it protects young women. HPV is the ... linked to penile cancer and other malignancies in men. According ... New England Journal of Medicine , which was funded by the ...
... Phil predicted that spring will come on time, and NASA ... the U.S. are now anxious for the prediction to come ... over the last couple of days, including Phil,s home at ... and freezing rain this morning before it changed to snow ...
... Feb. 2 (HealthDay News) -- Researchers report that DNA analysis ... rare vascular disease, along with its genetic cause. As ... England Journal of Medicine , the debilitating, painful and progressive ... the hands and feet of patients, and in the vascular ...
... By Jenifer Goodwin HealthDay Reporter , ... autism have difficulty understanding others, intentions, new research shows. ... with autism, even those with high IQs, judge others ... maintaining relationships, the study found. Researchers from Massachusetts ...
Cached Medicine News:Health News:Younger immigrants adjust to a new culture faster than do older immigrants 2Health News:New national study finds mountain bike-related injuries down 56 percent 2Health News:Gardasil Vaccine Guards Against HPV in Boys 2Health News:GOES-13 Satellite sees Groundhog's Day on ice 2Health News:Scientists Discover Rare Vascular Disease 2Health News:Adults With Autism May Not Understand Others' Intentions 2Health News:Adults With Autism May Not Understand Others' Intentions 3
VG2 PLIF (Trapezoid) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit co...
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Solid cortical spacers with a natural anatomic fibular shape....
Medicine Products: